Atherosclerosis

Genetic risk scoring not ready for prime time in heart disease
By Emily Hayes
One study evaluated risk scoring in a cohort of participants in UK Biobank, a nonprofit research project that is performing whole genome sequencing on a mass scale in the U.K. The observational study assessed polygenic risk scores, pooled cohort equations (risk prediction models), and both combined for predicting events in 352,660 participants with no cardiovascular disease at baseline.
February 18, 2020
2019 11 15 19 27 0360 Heart Scan 400
Blood test spots diabetes complications early on
By Joseph Constance
The development is significant for patients with type 2 diabetes because if vascular complications, such as heart disease, atherosclerosis, or kidney failure, are detected at an early stage, preventive treatments could be given to avoid severe clinical outcomes down the line.
October 1, 2019
2019 07 31 21 43 0672 Diabetes Type 2 400
Inflammation marker in blood linked to early death in army recruits
By Emily Hayes
There was a significant association between erythrocyte sedimentation rate (ESR) and overall mortality, cardiovascular death, and cancer mortality decades later in the study of 106,120 male recruits, according to registry data spanning approximately 30 years in Sweden, reported Elizabeth Kantor, PhD, an epidemiologist at Memorial Sloan Kettering Cancer Center, and colleagues in a research letter.
September 3, 2019
2019 08 30 17 12 7215 Military 400
Cardiologists back more screening, tight LDL and glucose control
By Emily Hayes
Screening involves testing for a high level of low-density lipoprotein cholesterol (LDL-C) and identifying a history of early personal and/or familial heart disease. The diagnosis can be confirmed with a genetic test that is widely available in Europe, the ESC noted in a statement about the research at the meeting, held jointly with the World Heart Federation's WCC from August 31 to September 4 in Paris.
September 2, 2019
2019 09 03 21 36 1431 Heart Ekg 400
Page 1 of 1